Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

Our study thus confirmed what was found in people of African descent in the US: the genetic origin underpinning the excess ...

Nearly all children with ANCA-associated vasculitis demonstrate active kidney disease at diagnosis, and their renal function ...

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study. By creating the most complete and detailed genetic 'map' of kidney function to ...

"Heart failure and kidney failure often go hand in hand," he told Newsweek, adding that the kidneys control the way the body handles salt and water. If they are not getting rid of these substances ...

Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with ...

An unusual swelling in the legs and feet could indicate the onset of kidney damage. When the kidneys struggle to eliminate ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

Kidney disease is a growing health concern in Australia, with many people unaware that they are affected. According to ...

There is no standard approach to starting kidney transplant evaluations in patients referred from dialysis facilities to ...